INDAPAMID STADA
1,5MG TBL PRO 100
Announcement of launch, break or close-out of marketing of a medicinal product
| Type of announcement | Effective date | Alternate medicines ? | Reason for interruption/cessation of marketing | Estimated renewal date |
|---|---|---|---|---|
| Resumption of marketing | 13.10.2022 | |||
| Interruption of marketing | 08.09.2022 |
0124414, 0124416, 0151034, 0020031 |
Manufacturing reasons | 31.10.2022 |
| Resumption of marketing | 23.02.2022 | |||
| Interruption of marketing | 17.01.2022 |
0120325, 0124414, 0124416, 0151034, 0020031 |
Manufacturing reasons | 31.01.2022 |
| Resumption of marketing | 21.07.2020 | |||
| Interruption of marketing | 11.09.2019 |
0124414, 0124416, 0020031 |
Capacity/distribution reasons | listopad 2019 |
| Resumption of marketing | 16.01.2019 | |||
| Interruption of marketing | 20.12.2018 |
0120325, 0124414, 0124416, 0012581, 0151034, 0020031 |
Commercial/marketing reasons | 15.1.2019 |
| Placing on the market | 05.02.2010 |
All reports are available in the Overview.
cz